The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bombardier, C., Laine, L., Reicin, A., Shapiro, D., Burgos-Vargas, R., Davis, B., Day, R., Ferraz, M. B., Hawkey, C. J., Hochberg, M. C., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011233432103 · Cited by 4,027
Oshima, M., Dinchuk, J. E., Kargman, S. L., Oshima, H., Hancock, B., Kwong, E., Trzaskos, J. M., Evans, J. F., & Taketo, M. M. (1996) · Cell · doi:10.1016/s0092-8674(00)81988-1 · Cited by 2,366
Rising incidence of adenocarcinoma of the esophagus and gastric cardia
Blot, W. J. (1991) · JAMA · doi:10.1001/jama.265.10.1287 · Cited by 2,354
Risk of Cardiovascular Events Associated with Selective COX-2 Inhibitors
Mukherjee, D. (2001) · JAMA · doi:10.1001/jama.286.8.954 · Cited by 1,741
Seibert, K., Zhang, Y., Leahy, K., Hauser, S., Masferrer, J., Perkins, W., Lee, L., & Isakson, P. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.12013 · Cited by 1,551
Is there publication bias in the reporting of cancer risk in Barrett's esophagus?
Shaheen, N. J., Crosby, M. A., Bozymski, E. M., & Sandler, R. S. (2000) · Gastroenterology · doi:10.1053/gast.2000.9302 · Cited by 758
The Incidence of Adenocarcinoma in Columnar-Lined (Barrett's) Esophagus
Cameron, A. J., Ott, B. J., & Payne, W. S. (1985) · New England Journal of Medicine · doi:10.1056/nejm198510033131404 · Cited by 715
Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2.
Sheng, H., Shao, J., Kirkland, S. C., Isakson, P., Coffey, R. J., Morrow, J., Beauchamp, R. D., & DuBois, R. N. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119400 · Cited by 712
Winters, C., Spurling, T. J., Chobanian, S. J., Curtis, D. J., Esposito, R. L., Hacker, J. F., Johnson, D. A., Cruess, D. F., Cotelingam, J. D., Gurney, M. S., et al. (1987) · Gastroenterology · doi:10.1016/0016-5085(87)90847-x · Cited by 689
Spechler, S. J., & Goyal, R. K. (1986) · New England Journal of Medicine · doi:10.1056/nejm198608073150605 · Cited by 660
Wilson, K. T., Fu, S., Ramanujam, K. S., & Meltzer, S. J. (1998) · PubMed · Cited by 591
Approaches to nonsteroidal anti-inflammatory drug use in the high-risk patient
Laine, L. (2001) · Gastroenterology · doi:10.1053/gast.2001.21907 · Cited by 548
Kargman, S., Charleson, S., Cartwright, M., Frank, J., Riendeau, D., Mancini, J., Evans, J., & O'Neill, G. (1996) · Gastroenterology · doi:10.1053/gast.1996.v111.pm8690211 · Cited by 462
Shirvani, V. N., Ouatu-Lascar, R., Kaur, B. S., Omary, M. B., & Triadafilopoulos, G. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70254-x · Cited by 443
Farrow, D. C., Vaughan, T. L., Hansten, P. D., et al. (1998) · PubMed · Cited by 416
Piazza, G. A., Rahm, A. K., Finn, T. S., Fryer, B., Li, H., Stoumen, A. L., Pamukcu, R., & Ahnen, D. J. (1997) · PubMed · Cited by 375
Souza, R. F., Shewmake, K., Beer, D. G., Cryer, B., & Spechler, S. J. (2000) · PubMed · Cited by 315
Dynamic effects of acid on Barrett's esophagus. An ex vivo proliferation and differentiation model.
Fitzgerald, R. C., Omary, M. B., & Triadafilopoulos, G. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119018 · Cited by 315
Inhibition of Cyclooxygenase: A Novel Approach to Cancer Prevention
Subbaramaiah, K., Zakim, D., Weksler, B. B., & Dannenberg, A. J. (1997) · Experimental Biology and Medicine · doi:10.3181/00379727-216-44170 · Cited by 222
Sulindac derivatives inhibit growth and induce apoptosis in human prostate cancer cell lines
Lim, J. T. E., Piazza, G. A., Han, E. K.-H., Delohery, T. M., Han, L., Finn, T. S., Buttyan, R., Yamamoto, H., Sperl, G. J., Brendel, K., et al. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00200-2 · Cited by 209
Risk of cardiovascular events associated with selective COX-2 inhibitors
Mukherjee, D., Nissen, S. E., & Topol, E. J. (2002) · ACC Current Journal Review · doi:10.1016/s1062-1458(01)00545-1 · Cited by 208
Riendeau, D., Charleson, S., Cromlish, W., Mancini, J. A., Wong, E., & Guay, J. (1997) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-75-9-1088 · Cited by 186
Reflux of duodenal or gastro-duodenal contents induces esophageal carcinoma in rats
Miwa, K., Sahara, H., Segawa, M., Kinami, S., Sato, T., Miyazaki, I., & Hattori, T. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960717)67:2<269::aid-ijc19>3.0.co;2-6 · Cited by 184
Goldstein, S., Yang, G. Y., Curtis, S. K., Reuhl, K. R., Liu, B. C., Mirvish, S. S., Newmark, H. L., & Yang, C. S. (1997) · Carcinogenesis · doi:10.1093/carcin/18.11.2265 · Cited by 154
Mahmoud, N. (1998) · Carcinogenesis · doi:10.1093/carcin/19.1.87 · Cited by 138
Duodenoesophageal reflux induces esophageal adenocarcinoma without exogenous carcinogen
Fein, M., Peters, J. H., Chandrasoma, P., Ireland, A. P., Öberg, S., Ritter, M. P., Bremner, C. G., Hagen, J. A., & DeMeester, T. R. (1998) · Journal of Gastrointestinal Surgery · doi:10.1016/s1091-255x(98)80021-8 · Cited by 130
Lanza, F. L. (1989) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365528909091171 · Cited by 125
Influence of pancreatic and biliary reflux on the development of esophageal carcinoma
Pera, M., Trastek, V. F., Carpenter, H. A., Fernández, P. L., Cardesa, A., Möhr, U., & Pairolero, P. C. (1993) · The Annals of Thoracic Surgery · doi:10.1016/0003-4975(93)91077-z · Cited by 121
Cyclooxygenase, NSAIDs, and colorectal cancer
DuBois, R. N., & Smalley, W. E. (1996) · Journal of Gastroenterology · doi:10.1007/bf02358623 · Cited by 119
Goldstein, S., y Yang, G., Chen, X., Curtis, S. K., & Yang, C. S. (1998) · Carcinogenesis · doi:10.1093/carcin/19.8.1445 · Cited by 82
Fitzgerald, R. C., Omary, M. B., & Triadafilopoulos, G. (1998) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1998.275.1.g47 · Cited by 77
Acid modulation of HT29 cell growth and differentiation An in vitro model for Barrett’s esophagus
Fitzgerald, R. C., Omary, M. B., & Triadafilopoulos, G. (1997) · Journal of Cell Science · doi:10.1242/jcs.110.5.663 · Cited by 66
Carcinoma of the oesophagus: The time for a multidiciplinary approach?
Clark, G. W. B., Roy, M. K., Corcoran, B. A., & Carey, P. D. (1996) · Surgical Oncology · doi:10.1016/s0960-7404(96)80038-7 · Cited by 20
Cited by
Updated Guidelines 2008 for the Diagnosis, Surveillance and Therapy of Barrett's Esophagus
Wang, K. K., & Sampliner, R. E. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.01835.x · Cited by 2,014
Self-citationAmerican Gastroenterological Association Technical Review on the Management of Barrett's Esophagus
Spechler, S. J., Sharma, P., Souza, R. F., Inadomi, J. M., & Shaheen, N. J. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.01.031 · Cited by 1,060
Cyclooxygenase 2: a molecular target for cancer prevention and treatment
Subbaramaiah, K., & Dannenberg, A. J. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)00043-3 · Cited by 649
Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic
Warner, T. D., & Mitchell, J. A. (2004) · The FASEB Journal · doi:10.1096/fj.03-0645rev · Cited by 614
Souza, R. F., Huo, X., Mittal, V., Schuler, C. M., Carmack, S. W., Zhang, H. Y., Zhang, X., Yu, C., Hormi–Carver, K., Genta, R. M., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.07.055 · Cited by 406
Metadata
- Authors
- Buttar, N. S., Wang, K. K., Leontovich, O., Westcott, J. Y., Pacifico, R. J., Anderson, M. A., Krishnadath, K. K., Lutzke, L. S., & Burgart, L. J.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2002-04
- Volume
- 122
- Issue
- 4
- Pages
- 1101-1112
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W1997850959
- Cited by
- 348
- References
- 33
- FWCI
- 29.34
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.